RFL Stock Overview
Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rafael Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.91 |
| 52 Week High | US$2.50 |
| 52 Week Low | US$1.29 |
| Beta | 1.07 |
| 11 Month Change | 6.70% |
| 3 Month Change | 29.05% |
| 1 Year Change | 3.80% |
| 33 Year Change | -67.63% |
| 5 Year Change | -88.71% |
| Change since IPO | -61.02% |
Recent News & Updates
Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet?
Oct 11
Solid Earnings May Not Tell The Whole Story For Rafael Holdings (NYSE:RFL)
Mar 21Recent updates
Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet?
Oct 11Solid Earnings May Not Tell The Whole Story For Rafael Holdings (NYSE:RFL)
Mar 21We Think Rafael Holdings (NYSE:RFL) Needs To Drive Business Growth Carefully
Aug 04Rafael Holdings GAAP EPS of -$0.22
Dec 13Rafael stepping back from early-stage development in favor of acquisition, licensing
Nov 16Is Rafael Holdings (NYSE:RFL) Using Debt In A Risky Way?
Jan 20Rafael Holdings: A Coin Flip
Nov 18Rafael Holdings announces merger with Rafael Pharmaceuticals
Jun 21Rafael Holdings adds three new members to board
Jun 14What You Need To Know About Rafael Holdings, Inc.'s (NYSE:RFL) Investor Composition
Jan 25
Rafael Holdings reports FQ1 results
Dec 15The Rafael Holdings (NYSE:RFL) Share Price Has Gained 29% And Shareholders Are Hoping For More
Dec 01Shareholder Returns
| RFL | US Real Estate | US Market | |
|---|---|---|---|
| 7D | 4.4% | 5.7% | 2.2% |
| 1Y | 3.8% | 29.1% | 31.6% |
Return vs Industry: RFL underperformed the US Real Estate industry which returned 29% over the past year.
Return vs Market: RFL underperformed the US Market which returned 31.7% over the past year.
Price Volatility
| RFL volatility | |
|---|---|
| RFL Average Weekly Movement | 7.6% |
| Real Estate Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RFL has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: RFL's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 30 | Bill Conkling | www.rafaelholdings.com |
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
Rafael Holdings, Inc. Fundamentals Summary
| RFL fundamental statistics | |
|---|---|
| Market cap | US$47.13m |
| Earnings (TTM) | -US$34.41m |
| Revenue (TTM) | US$637.00k |
74.0x
P/S Ratio-1.4x
P/E RatioIs RFL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RFL income statement (TTM) | |
|---|---|
| Revenue | US$637.00k |
| Cost of Revenue | US$154.00k |
| Gross Profit | US$483.00k |
| Other Expenses | US$34.89m |
| Earnings | -US$34.41m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.39 |
| Gross Margin | 75.82% |
| Net Profit Margin | -5,401.88% |
| Debt/Equity Ratio | 2.8% |
How did RFL perform over the long term?
See historical performance and comparison